FDA tracker
PT-141: FDA regulatory status
FDA approvedUpdated Apr 23, 2026
FDA approved 2019 (HSDD, women)
Editorially reviewedThe Peptide Examiner editorial team, Editorial review · Reviewed Apr 23, 2026
Regulatory notes
No peptide-specific FDA regulatory events tracked yet. See the full FDA enforcement timeline for the broader regulatory context.
What this means for patients
PT-141 is FDA approved. Access is through a clinician prescription and a licensed pharmacy. Insurance coverage depends on the approved indication and your plan's formulary.